Human Phenotype Ontology 
Grandparent Node:
expand
Abnormality of the skin (HP:0000951)help
Grandparent Node:
expand
Neoplasm by anatomical site (HP:0011793)help
Parent Node:
expand
Neoplasm of the skin (HP:0008069)help
..Starting node
..expand
Basal cell carcinoma (HP:0002671)help
Term ID: 2671
Name: Basal cell carcinoma
Synonym: Basal cell carcinomas; Basal cell epithelioma; Basal cell nevus; Basalioma
Definition: The presence of a basal cell carcinoma of the skin.
Comments:
Reference: HP:0002671
Genes and Diseases:
 
       Child Nodes:
........expandBasalioma of the outer ear (HP:0040098) help

 Sister Nodes: 
..expandAcanthoma (HP:0025432) help
..expandActinic keratosis (HP:0025127) help
..expandAdenoma sebaceum (HP:0009720) help
..expandCutaneous angiolipomas (HP:0006773) help
..expandCutaneous leiomyoma (HP:0007620) help
..expandCutaneous leiomyosarcoma (HP:0006755) help
..expandCutaneous mastocytosis (HP:0200151) help
..expandCutaneous melanoma (HP:0012056) help
..expandCutaneous myxoma (HP:0030428) help
..expandEccrine syringofibroadenoma (HP:0031018) help
..expandFibrofolliculoma (HP:0030436) help
..expandFrontal cutaneous lipoma (HP:0007541) help
..expandKaposi's sarcoma (HP:0100726) help
..expandKeratoacanthoma (HP:0031525) help
..expandLymphocytoma cutis (HP:0031549) help
..expandMerkel cell skin cancer (HP:0030447) help
..expandMultiple cutaneous leiomyomas (HP:0007437) help
..expandMultiple cutaneous malignancies (HP:0007606) help
..expandMyxoid subcutaneous tumors (HP:0006769) help
..expandNeurofibromas (HP:0001067) help
..expandPapilloma (HP:0012740) help
..expandPeripheral Schwannoma (HP:0009593) help
..expandSeborrheic keratosis (HP:0031287) help
..expandSkin appendage neoplasm (HP:0012842) help
..expandSquamous cell carcinoma (HP:0002860) help
..expandSteatocystoma multiplex (HP:0012035) help
..expandSubcutaneous lipoma (HP:0001031) help
InputHPO IDHPO termDistanceGeneGene id entrezHGNC IDDiseaseIdDiseaseNameFrequencyOnsetHGMD variantsClinVar variants
 
HPO disease - gene - phenotype typical associations:
 
HPO disease - gene - phenotype less frequent non-typical associations:
HP:0002671HP:0002671Basal cell carcinoma0AAGAB CL E G H7971925662ORPHA:79501Punctate palmoplantar keratoderma type 1HP:0040284 - Very rare7
HP:0002671HP:0002671Basal cell carcinoma0ANAPC1 CL E G H6468219988ORPHA:221008Rothmund-Thomson syndrome type 1HP:0040284 - Very rare2
HP:0002671HP:0002671Basal cell carcinoma0APC CL E G H324583ORPHA:99818Turcot syndrome with polyposisHP:0040284 - Very rare3179
HP:0002671HP:0002671Basal cell carcinoma0BMPR1A CL E G H6571076ORPHA:440437Familial colorectal cancer Type XHP:0040283 - Occasional385
HP:0002671HP:0002671Basal cell carcinoma0CASP10 CL E G H8431500ORPHA:3261Autoimmune lymphoproliferative syndromeHP:0040284 - Very rare87
HP:0002671HP:0002671Basal cell carcinoma0CIB1 CL E G H1051916920OMIM:618267Epidermodysplasia verruciformis, susceptibility to, 3.
HP:0002671HP:0002671Basal cell carcinoma0COL14A1 CL E G H73732191ORPHA:79501Punctate palmoplantar keratoderma type 1HP:0040284 - Very rare2
HP:0002671HP:0002671Basal cell carcinoma0CYLD CL E G H15402584ORPHA:867Familial multiple trichoepitheliomaHP:0040283 - Occasional126
HP:0002671HP:0002671Basal cell carcinoma0CYLD CL E G H15402584OMIM:601606Trichoepithelioma, multiple familial, 1HP:0040283 - Occasional126
HP:0002671HP:0002671Basal cell carcinoma0DDB2 CL E G H16432718OMIM:278740Xeroderma pigmentosum, complementation group E.30
HP:0002671HP:0002671Basal cell carcinoma0DICER1 CL E G H2340517098ORPHA:276399Familial multinodular goiterHP:0040282 - Frequent670
HP:0002671HP:0002671Basal cell carcinoma0EPCAM CL E G H407211529ORPHA:144Lynch syndromeHP:0040283 - Occasional170
HP:0002671HP:0002671Basal cell carcinoma0ERCC2 CL E G H20683434OMIM:601675Trichothiodystrophy 1, photosensitive.106
HP:0002671HP:0002671Basal cell carcinoma0ERCC2 CL E G H20683434ORPHA:220295Xeroderma pigmentosum-Cockayne syndrome complexHP:0040282 - Frequent106
HP:0002671HP:0002671Basal cell carcinoma0ERCC3 CL E G H20713435OMIM:610651Xeroderma pigmentosum, complementation group B.54
HP:0002671HP:0002671Basal cell carcinoma0ERCC3 CL E G H20713435ORPHA:220295Xeroderma pigmentosum-Cockayne syndrome complexHP:0040282 - Frequent54
HP:0002671HP:0002671Basal cell carcinoma0ERCC4 CL E G H20723436OMIM:278760Xeroderma pigmentosum, complementation group F158
HP:0002671HP:0002671Basal cell carcinoma0ERCC4 CL E G H20723436ORPHA:220295Xeroderma pigmentosum-Cockayne syndrome complexHP:0040282 - Frequent158
HP:0002671HP:0002671Basal cell carcinoma0ERCC5 CL E G H20733437ORPHA:220295Xeroderma pigmentosum-Cockayne syndrome complexHP:0040282 - Frequent83
HP:0002671HP:0002671Basal cell carcinoma0FAN1 CL E G H2290929170ORPHA:144Lynch syndromeHP:0040283 - Occasional15
HP:0002671HP:0002671Basal cell carcinoma0FAS CL E G H35511920ORPHA:3261Autoimmune lymphoproliferative syndromeHP:0040284 - Very rare59
HP:0002671HP:0002671Basal cell carcinoma0FASLG CL E G H35611936ORPHA:3261Autoimmune lymphoproliferative syndromeHP:0040284 - Very rare37
HP:0002671HP:0002671Basal cell carcinoma0FOXE1 CL E G H23043806OMIM:616534Thyroid cancer, nonmedullary, 49
HP:0002671HP:0002671Basal cell carcinoma0HRAS CL E G H32655173ORPHA:2874Phakomatosis pigmentokeratotica113
HP:0002671HP:0002671Basal cell carcinoma0HRAS CL E G H32655173OMIM:163200Schimmelpenning-Feuerstein-Mims syndrome.113
HP:0002671HP:0002671Basal cell carcinoma0KEAP1 CL E G H981723177ORPHA:276399Familial multinodular goiterHP:0040282 - Frequent
HP:0002671HP:0002671Basal cell carcinoma0KRAS CL E G H38456407ORPHA:144Lynch syndromeHP:0040283 - Occasional196
HP:0002671HP:0002671Basal cell carcinoma0KRAS CL E G H38456407OMIM:163200Schimmelpenning-Feuerstein-Mims syndrome.196
HP:0002671HP:0002671Basal cell carcinoma0LMNA CL E G H40006636ORPHA:363618LMNA-related cardiocutaneous progeria syndromeHP:0040281 - Very frequent645
HP:0002671HP:0002671Basal cell carcinoma0MC1R CL E G H41576929ORPHA:79432Oculocutaneous albinism type 2HP:0040283 - Occasional124
HP:0002671HP:0002671Basal cell carcinoma0MLH1 CL E G H42927127ORPHA:144Lynch syndromeHP:0040283 - Occasional1819
HP:0002671HP:0002671Basal cell carcinoma0MLH1 CL E G H42927127OMIM:276300Mismatch repair cancer syndrome 1.1819
HP:0002671HP:0002671Basal cell carcinoma0MLH1 CL E G H42927127OMIM:158320Muir-Torre syndrome.1819
HP:0002671HP:0002671Basal cell carcinoma0MLH3 CL E G H270307128ORPHA:144Lynch syndromeHP:0040283 - Occasional131
HP:0002671HP:0002671Basal cell carcinoma0MSH2 CL E G H44367325ORPHA:144Lynch syndromeHP:0040283 - Occasional2162
HP:0002671HP:0002671Basal cell carcinoma0MSH2 CL E G H44367325OMIM:158320Muir-Torre syndrome.2162
HP:0002671HP:0002671Basal cell carcinoma0MSH6 CL E G H29567329ORPHA:144Lynch syndromeHP:0040283 - Occasional2232
HP:0002671HP:0002671Basal cell carcinoma0NRAS CL E G H48937989OMIM:163200Schimmelpenning-Feuerstein-Mims syndrome.102
HP:0002671HP:0002671Basal cell carcinoma0NTHL1 CL E G H49138028OMIM:616415Familial adenomatous polyposis 32
HP:0002671HP:0002671Basal cell carcinoma0NTHL1 CL E G H49138028ORPHA:454840NTHL1-related attenuated familial adenomatous polyposisHP:0040283 - Occasional2
HP:0002671HP:0002671Basal cell carcinoma0OCA2 CL E G H49488101ORPHA:79432Oculocutaneous albinism type 2HP:0040283 - Occasional121
HP:0002671HP:0002671Basal cell carcinoma0PIK3CA CL E G H52908975ORPHA:144Lynch syndromeHP:0040283 - Occasional162
HP:0002671HP:0002671Basal cell carcinoma0PMS1 CL E G H53789121ORPHA:144Lynch syndromeHP:0040283 - Occasional56
HP:0002671HP:0002671Basal cell carcinoma0PMS2 CL E G H53959122ORPHA:144Lynch syndromeHP:0040283 - Occasional1121
HP:0002671HP:0002671Basal cell carcinoma0POLH CL E G H54299181ORPHA:90342Xeroderma pigmentosum variantHP:0040282 - Frequent155
HP:0002671HP:0002671Basal cell carcinoma0POLH CL E G H54299181OMIM:278750Xeroderma pigmentosum, Variant type.155
HP:0002671HP:0002671Basal cell carcinoma0PRKCD CL E G H55809399ORPHA:3261Autoimmune lymphoproliferative syndromeHP:0040284 - Very rare10
HP:0002671HP:0002671Basal cell carcinoma0PTCH1 CL E G H57279585OMIM:605462Basal cell carcinoma, susceptibility to, 1.665
HP:0002671HP:0002671Basal cell carcinoma0PTCH1 CL E G H57279585OMIM:109400Basal cell nevus syndrome665
HP:0002671HP:0002671Basal cell carcinoma0PTCH1 CL E G H57279585ORPHA:77301Monosomy 9q22.3HP:0040281 - Very frequent665
HP:0002671HP:0002671Basal cell carcinoma0PTCH2 CL E G H86439586OMIM:605462Basal cell carcinoma, susceptibility to, 1.40
HP:0002671HP:0002671Basal cell carcinoma0PTCH2 CL E G H86439586OMIM:109400Basal cell nevus syndrome40
HP:0002671HP:0002671Basal cell carcinoma0RASA1 CL E G H59219871OMIM:605462Basal cell carcinoma, susceptibility to, 1.88
HP:0002671HP:0002671Basal cell carcinoma0RASGRP1 CL E G H101259878ORPHA:3261Autoimmune lymphoproliferative syndromeHP:0040284 - Very rare
HP:0002671HP:0002671Basal cell carcinoma0RECQL4 CL E G H94019949ORPHA:221016Rothmund-Thomson syndrome type 2HP:0040283 - Occasional445
HP:0002671HP:0002671Basal cell carcinoma0RECQL4 CL E G H94019949OMIM:268400ROTHMUND-THOMSON SYNDROME; RTS445
HP:0002671HP:0002671Basal cell carcinoma0RMRP CL E G H602310031OMIM:250250Cartilage-Hair hypoplasia37
HP:0002671HP:0002671Basal cell carcinoma0RPS20 CL E G H622410405ORPHA:440437Familial colorectal cancer Type XHP:0040283 - Occasional1
HP:0002671HP:0002671Basal cell carcinoma0SEMA4A CL E G H6421810729ORPHA:440437Familial colorectal cancer Type XHP:0040283 - Occasional48
HP:0002671HP:0002671Basal cell carcinoma0SMO CL E G H660811119OMIM:605462Basal cell carcinoma, susceptibility to, 1.22
HP:0002671HP:0002671Basal cell carcinoma0SUFU CL E G H5168416466OMIM:109400Basal cell nevus syndrome124
HP:0002671HP:0002671Basal cell carcinoma0TGFBR2 CL E G H704811773ORPHA:144Lynch syndromeHP:0040283 - Occasional253
HP:0002671HP:0002671Basal cell carcinoma0TMC6 CL E G H1132218021OMIM:226400Epidermodysplasia verruciformis, susceptibility to, 1.10
HP:0002671HP:0002671Basal cell carcinoma0TYMS CL E G H729812441OMIM:6200401
HP:0002671HP:0002671Basal cell carcinoma0TYR CL E G H729912442ORPHA:79431Oculocutaneous albinism type 1AHP:0040283 - Occasional146
HP:0002671HP:0002671Basal cell carcinoma0TYR CL E G H729912442ORPHA:79434Oculocutaneous albinism type 1BHP:0040283 - Occasional146
HP:0002671HP:0002671Basal cell carcinoma0WNT10A CL E G H8032613829ORPHA:50944Schöpf-Schulz-Passarge syndromeHP:0040283 - Occasional71
HP:0002671HP:0002671Basal cell carcinoma0WNT10A CL E G H8032613829OMIM:224750Schopf-Schulz-Passarge syndrome.71
HP:0002671HP:0002671Basal cell carcinoma0XPC CL E G H750812816OMIM:278720Xeroderma pigmentosum, complementation group C.86
HP:0002671HP:0040098Basalioma of the outer ear1 CL E G H


Genes (52) :AAGAB ANAPC1 APC BMPR1A CASP10 CIB1 COL14A1 CYLD DDB2 DICER1 EPCAM ERCC2 ERCC3 ERCC4 ERCC5 FAN1 FAS FASLG FOXE1 HRAS KEAP1 KRAS LMNA MC1R MLH1 MLH3 MSH2 MSH6 NRAS NTHL1 OCA2 PIK3CA PMS1 PMS2 POLH PRKCD PTCH1 PTCH2 RASA1 RASGRP1 RECQL4 RMRP RPS20 SEMA4A SMO SUFU TGFBR2 TMC6 TYMS TYR WNT10A XPC

Diseases (39) :ORPHA:79501 ORPHA:221008 ORPHA:99818 ORPHA:440437 ORPHA:3261 OMIM:618267 ORPHA:867 OMIM:601606 OMIM:278740 ORPHA:276399 ORPHA:144 OMIM:601675 ORPHA:220295 OMIM:610651 OMIM:278760 OMIM:616534 ORPHA:2874 OMIM:163200 ORPHA:363618 ORPHA:79432 OMIM:276300 OMIM:158320 OMIM:616415 ORPHA:454840 ORPHA:90342 OMIM:278750 OMIM:605462 OMIM:109400 ORPHA:77301 ORPHA:221016 OMIM:268400 OMIM:250250 OMIM:226400 OMIM:620040 ORPHA:79431 ORPHA:79434 ORPHA:50944 OMIM:224750 OMIM:278720
 

Human Phenotype Ontology(HPO) is developed by the Human Phenotype Ontology Consortium. The version used here is December 15 2022 release.